All In Biotech

Free tool

FAERS Monitor: Remodulin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208276 or its brand name (Remodulin, Treprostinil). Reports on generic versions are filed under their own applications.

Reports

64,707

Serious

41,543

64% of reports

Hospitalization

30,991

Death reported

9,004

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea9,869
  • headache7,151
  • diarrhoea6,878
  • nausea6,178
  • infusion site pain5,787
  • death5,212
  • fatigue4,057
  • dizziness3,833
  • vomiting3,379
  • infusion site erythema3,348
  • pain in extremity2,962
  • hypotension2,833
  • pulmonary arterial hypertension2,822
  • malaise2,789
  • pneumonia2,674

Reports by year received

View as table
YearReports
200431
200558
200686
200739
200831
200964
2010889
20111,616
2012642
2013998
20144,571
20155,443
20164,819
20174,835
20185,286
20194,950
20204,256
20214,001
20224,300
20235,013
20244,579
20254,856
20263,344

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,989,452 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion site painSignal5,787263.9255.1836,104
infusion site erythemaSignal3,348213.3204.4426,866
pulmonary arterial hypertensionSignal2,82278.475.3173,633
dyspnoeaSignal9,8695.75.639,093
hypotensionSignal2,8334.64.58,054
headacheSignal7,1513.73.714,615
diarrhoeaSignal6,8783.53.412,469
pain in extremitySignal2,9623.33.24,740
pneumoniaSignal2,6742.72.62,878
nauseaSignal6,1782.52.55,996
dizzinessSignal3,8332.52.43,536
vomitingSignal3,3792.32.32,648
malaiseSignal2,7892.12.01,573
death5,2122.01.92,588
fatigue4,0571.71.61,200

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.